AR023645A1 - Metodo para tratar una infeccion por estafilococos - Google Patents
Metodo para tratar una infeccion por estafilococosInfo
- Publication number
- AR023645A1 AR023645A1 ARP990104279A ARP990104279A AR023645A1 AR 023645 A1 AR023645 A1 AR 023645A1 AR P990104279 A ARP990104279 A AR P990104279A AR P990104279 A ARP990104279 A AR P990104279A AR 023645 A1 AR023645 A1 AR 023645A1
- Authority
- AR
- Argentina
- Prior art keywords
- treat
- staphilocos
- infection
- staphylococcal infections
- lisostafine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
- C12Y304/24075—Lysostaphin (3.4.24.75)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
La lisostafina es un antibiotico eficaz para el tratamiento de infecciones estafilococicas. Grandes dosis de lisostafina o de análogos de lisostafina soneficaces a corto plazo, o incluso en administraciones de una sola dosis, para tratar y erradicarinfecciones estafilococicas, incluyendo las que sonresistentes a los antibioticos convencionales.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/140,732 US6028051A (en) | 1997-07-23 | 1998-08-27 | Method for the treatment of staphylococcal disease |
Publications (1)
Publication Number | Publication Date |
---|---|
AR023645A1 true AR023645A1 (es) | 2002-09-04 |
Family
ID=22492556
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP990104279A AR023645A1 (es) | 1998-08-27 | 1999-08-26 | Metodo para tratar una infeccion por estafilococos |
Country Status (12)
Country | Link |
---|---|
US (1) | US6028051A (es) |
EP (1) | EP1107722B1 (es) |
JP (1) | JP2002523437A (es) |
AR (1) | AR023645A1 (es) |
AT (1) | ATE493145T1 (es) |
AU (1) | AU5811199A (es) |
CA (1) | CA2341699A1 (es) |
DE (1) | DE69943089D1 (es) |
IL (1) | IL141648A0 (es) |
NO (1) | NO20010953L (es) |
WO (1) | WO2000012049A2 (es) |
ZA (1) | ZA995444B (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6875903B2 (en) * | 1998-06-22 | 2005-04-05 | University Of Vermont | Treatment of Staphylococcus infections |
US7091332B1 (en) | 1998-06-22 | 2006-08-15 | University Of Vermont | Treatment of staphylococcus infections |
US6569830B1 (en) * | 1999-03-05 | 2003-05-27 | Ambi, Inc. | Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains |
US20030211995A1 (en) * | 2001-12-21 | 2003-11-13 | Kokai-Kun John Fitzgerald | Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin |
JP4348194B2 (ja) * | 2001-12-21 | 2009-10-21 | バイオシネクサス インコーポレーテッド | ブドウ球菌溶解活性が増強された切断型リゾスタフィン分子 |
US6759881B2 (en) * | 2002-03-22 | 2004-07-06 | Rambus Inc. | System with phase jumping locked loop circuit |
BR0308710A (pt) * | 2002-03-26 | 2007-01-09 | Biosynexus Inc | conjugados poliméricos antimicrobianos |
CA2476288A1 (en) * | 2002-03-26 | 2003-10-09 | Biosynexus Incorporated | Enzyme disruption of bacterial biofilms |
EP1585532A4 (en) * | 2002-12-10 | 2008-09-24 | Biosynexus Inc | TOPICAL INFECTION-INHIBITING FORMULATIONS |
US20100221237A1 (en) * | 2003-03-26 | 2010-09-02 | Biosynexus Incorporated | Enzyme disruption of bacterial biofilms |
WO2007041621A2 (en) * | 2005-10-03 | 2007-04-12 | Xingsheng Sean Ling | Hybridization assisted nanopore sequencing |
WO2008105826A2 (en) * | 2006-09-05 | 2008-09-04 | Biosynexus Incorporated | Compositions compromising lysostaphin variants and methods of using the same |
US20110044968A1 (en) * | 2008-03-10 | 2011-02-24 | Pharmal N Corporation | Compositions for treatment with metallopeptidases, methods of making and using the same |
US20090304673A1 (en) * | 2008-06-10 | 2009-12-10 | Bernd Buchberger | Method of Treatment of Inflammatory Diseases |
WO2015175774A1 (en) | 2014-05-14 | 2015-11-19 | Trustees Of Dartmouth College | Deimmunized lysostaphin and methods of use |
CN109819650A (zh) | 2017-09-25 | 2019-05-28 | 春布里泽·格奥尔基·格奥尔基耶维奇 | 具有抗病毒和抗细菌活性的热稳定组合物及其用途 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3067099A (en) * | 1955-09-16 | 1962-12-04 | Lilly Co Eli | Vancomycin and method for its preparation |
US4931390A (en) * | 1986-04-16 | 1990-06-05 | Public Health Research Institute Of The City Of New York, Inc. | Expression of the cloned lysostaphin gene |
US5858962A (en) * | 1987-05-11 | 1999-01-12 | Ambi Inc. | Composition for treating mastitis and other staphylococcal infections |
US4980163A (en) * | 1989-03-01 | 1990-12-25 | Public Health Research Institute Of The City Of New York | Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection |
US5342612A (en) * | 1991-12-20 | 1994-08-30 | American Cyanamid Company | Compositions for the treatment of mammalian diseases |
-
1998
- 1998-08-27 US US09/140,732 patent/US6028051A/en not_active Expired - Lifetime
-
1999
- 1999-08-25 ZA ZA9905444A patent/ZA995444B/xx unknown
- 1999-08-26 AR ARP990104279A patent/AR023645A1/es unknown
- 1999-08-27 DE DE69943089T patent/DE69943089D1/de not_active Expired - Lifetime
- 1999-08-27 WO PCT/US1999/020396 patent/WO2000012049A2/en active Application Filing
- 1999-08-27 AU AU58111/99A patent/AU5811199A/en not_active Abandoned
- 1999-08-27 AT AT99945525T patent/ATE493145T1/de not_active IP Right Cessation
- 1999-08-27 JP JP2000567170A patent/JP2002523437A/ja active Pending
- 1999-08-27 IL IL14164899A patent/IL141648A0/xx unknown
- 1999-08-27 EP EP99945525A patent/EP1107722B1/en not_active Expired - Lifetime
- 1999-08-27 CA CA002341699A patent/CA2341699A1/en not_active Abandoned
-
2001
- 2001-02-26 NO NO20010953A patent/NO20010953L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ATE493145T1 (de) | 2011-01-15 |
US6028051A (en) | 2000-02-22 |
NO20010953D0 (no) | 2001-02-26 |
DE69943089D1 (de) | 2011-02-10 |
EP1107722A2 (en) | 2001-06-20 |
JP2002523437A (ja) | 2002-07-30 |
NO20010953L (no) | 2001-03-21 |
CA2341699A1 (en) | 2000-03-09 |
EP1107722A4 (en) | 2006-05-17 |
AU5811199A (en) | 2000-03-21 |
WO2000012049A3 (en) | 2000-05-25 |
WO2000012049A2 (en) | 2000-03-09 |
EP1107722B1 (en) | 2010-12-29 |
ZA995444B (en) | 2000-07-10 |
IL141648A0 (en) | 2002-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR023645A1 (es) | Metodo para tratar una infeccion por estafilococos | |
ES2192201T3 (es) | Compuestos de piranona utiles para el tratamiento de infecciones retrovirales. | |
BR9510423A (pt) | Formulação lipossomal multilamelar de baixa rigidez processo de tratamento ou de profilaxia de uma infecção bacteriana em um animal e de uma variante mucoìde da mesma, uso da formulação lipossomal antibacteriana | |
ES2163504T3 (es) | Formas de dosificacion de liberacion controlada de azitromicina. | |
ES2074563T3 (es) | Procedimiento de preparacion de compuestos y metodo para el tratamiento de la septicemia y/o el choque septico. | |
EA200000594A1 (ru) | Новые макролиды | |
ATE336995T1 (de) | Aminocyclohexenchinoline und ihre azaisosterischen analoga mit antibakterieller wirkung | |
AR034746A1 (es) | Combinaciones para el tratamiento de trastornos inflamatorios | |
ES2186787T3 (es) | Utilizacion de ritonavir (abt-538) para mejorar la farmacocinetica de medicamentos metabolizados por el citocromo p450 en un metodo de tratamiento del sida. | |
ES541103A0 (es) | Procedimiento de obtencion de una composicion para el trata-miento de infecciones virales | |
BR0112750A (pt) | Aminopiperidina quinolinas e seus análogos azaisostéricos com atividade antibacteriana | |
ES2089687T3 (es) | 4-fenil-piridonas y 4-fenil-2-alcoxipiridinas sustituidas como inhibidores de la hmg-coa-reductasa. | |
ES2192101T3 (es) | Formas cristalinas de eto2c-ch2-(r)cgl-aze-pab-oh. | |
UY26678A1 (es) | El uso de composiciones a base de antibióticos de azalidos para tratar o prevenir una infección bacteriana o protozoaria en mamíferos | |
AR003176A1 (es) | Una composicion farmaceutica para inhibir el crecimiento de cancer | |
ES2042868T3 (es) | Un metodo de producir galidermina. | |
NO953995D0 (no) | Ionenolymere som anthelmintica i dyr | |
ES2136139T3 (es) | Componente farmaceutico de accion ralentizada que contiene acido bilico como componente activo. | |
ES2180774T3 (es) | La utilizacion de triacetato de glicerilo para el tratamiento de onicomicosis. | |
AR029544A1 (es) | Composiciones y metodos para tratar infecciones bacterianas | |
ATE258375T1 (de) | Behandlungen von der foulbroodbienenkrankheit | |
AR022250A1 (es) | Envase farmaceutico de uso para el tratamiento y prevencion de infecciones por el virus de la hepatitis b, procedimiento para el tratamiento de pacientes o pacientes susceptibles en padecer infecciones por el virus de la hepatitis b. | |
AR013411A1 (es) | Composicion de aplicacion para tratamientos antivirales y afecciones micosicas y/o bacterianas y utilizacion de dichas composiciones. | |
ES2194104T3 (es) | Uso de selegilina para el tratamiento de la perdida de audicion en mamiferos. | |
ES2126795T3 (es) | Formulacion y procedimiento de control de los nematodos parasitos de las plantas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |